Ivantis
Edit

Ivantis

http://www.ivantisinc.com/
Last activity: 15.09.2021
Categories: TechnologyProductMedTechHardwareDevelopmentCauseCare
Help control your eye pressure and possibly reduce your need for Glaucoma medication with the Hydrus® Microstent.
Mentions
13
Location: United States, California, Irvine
Total raised: $120.5M

Investors 8

Funding Rounds 5

DateSeriesAmountInvestors
10.01.2017Series C$25MRA Capital...
13.01.2014Series B$46.5M-
20.08.2013Series B$5M-
31.01.2013Series B$27M-
27.06.2011-$17M-

Mentions in press and media 13

DateTitleDescriptionSource
15.09.2021Ivantis Announces Settlement of Glaukos Patent Litigation IRVINE, Calif., Sept. 15, 2021 /PRNewswire/ -- Ivantis, Inc., developer of the novel Hydrus® Micro...prnewswire...
17.11.2020Hydrus Microstent Receives Highest Designation of Any MIGS D... IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ -- Ivantis Inc., developer of the novel Hydrus® Microst...prnewswire...
10.01.2017Term Sheet — Tuesday January 10ALL AI EVERYTHING Jocelyn Goldfein has worked on some of Silicon Valley’s most iconic products: She...fortune.co...
10.01.2017Singapore: EDBI & Vertex Ventures-backed Ivantis closes ...Premium Ivantis Inc., developer of the Hydrus Microstent device designed to lower eye pressure for ...dealstreet...
10.01.2017Ivantis Raises $25M in Series C FundingIvantis Inc., an Irvine, CA-based developer of a device designed to lower eye pressure for glaucoma ...finsmes.co...
09.01.2017 Ivantis Finds $25M For Microstent Surgery Devices Irvine-based medical device developer Ivantis, which is developing microstents for minimally invasiv...socaltech....
09.01.2017RA Capital Leads $25M Series C for IvantisIvantis Inc., developer of the novel Hydrus™ Microstent device designed to lower eye pressure for gl...citybizlis...
13.01.2014Ivantis Completes $46.5M Series B Financing IRVINE, CA, Developer of the novel Hydrus Microstent device designed to lower eye pressure for gla...vcnewsdail...
20.08.2013Ivantis Raises $5M in Second Close of Series B FinancingIvantis, an Irvine, California-based developer of a microstent device designed to lower eye pressure...finsmes.co...
01.02.2013Ivantis reels in $27M Series B round | Wall Street BeatIvantis said it raised a $27 million Series B round led by Ascension Health Ventures aimed at fundin...massdevice...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In